- Home
- INGR vs HALO Comparison
INGR vs HALO Comparison
Compare INGR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INGR | HALO |
|---|---|---|
| Founded | 1906 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.4B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | INGR | HALO |
|---|---|---|
| Price | $111.38 | $68.77 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 12 |
| Target Price | ★ $134.57 | $73.33 |
| AVG Volume (30 Days) | 759.1K | ★ 2.3M |
| Earning Date | 02-03-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | N/A | ★ 56.68 |
| EPS | ★ 10.01 | 4.74 |
| Revenue | ★ $7,262,000,000.00 | $1,242,852,000.00 |
| Revenue This Year | N/A | $34.83 |
| Revenue Next Year | $1.20 | $24.84 |
| P/E Ratio | ★ $11.13 | $14.54 |
| Revenue Growth | N/A | ★ 31.19 |
| 52 Week Low | $102.31 | $47.00 |
| 52 Week High | $141.78 | $79.50 |
Technical Indicators
Market Signals| Indicator | INGR | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 58.75 |
| Support Level | $110.00 | $61.23 |
| Resistance Level | $113.90 | $69.28 |
| Average True Range (ATR) | 1.71 | 1.69 |
| MACD | 0.31 | 0.69 |
| Stochastic Oscillator | 69.02 | 93.54 |
Price Performance
Historical ComparisonAbout INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.